Results 311 to 320 of about 425,098 (322)

An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects

International Journal of Antimicrobial Agents, 2004
exaly  

Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin

Infectious Disease Clinics of North America, 2009
exaly  

[Treatment of resistant Gram-positive bacterial infections].

Medecine et maladies infectieuses, 2012
openaire   +1 more source

Antibiotics for treatment of resistant gram-positive coccal infections

Indian Journal of Pediatrics, 2006
exaly  

Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: Results from a multicenter trial

Clinical Therapeutics, 2003
exaly  

Development of DNA polymerase IIIC inhibitors for the treatment of Gram-positive bacterial infections

Expert Opinion on Therapeutic Patents, 2005
exaly  

Glabridin pharmacodynamic activity toward Gram-positive bacterial infections

Food Bioscience
Chan Chen, Rui Sun, Tianle Pan, Lian Liu, Wenqiang Tang, Mi Wang, Lifang Zhang, Chenzhong Fei, Yingchun Liu   +8 more
openaire   +1 more source

Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study

Journal of Antimicrobial Chemotherapy
Luisa Sorlí, Santiago Grau, Sonia Luque
exaly  

Novobiocin in the Treatment of Surgical Infections Due to Staphylococci and Other Gram-Positive Bacteria

New England Journal of Medicine, 1956
exaly  

Anti-infectives: Novel carbapenem derivatives for combating Gram-positive bacterial infection

Expert Opinion on Therapeutic Patents, 1995
openaire   +1 more source